West Pharmaceutical CEO Plans Exit after 11 Years, Succession Process Underway

robot
Abstract generation in progress

Eric Green, CEO of West Pharmaceutical Services, Inc. (NYSE: WST), will retire after 11 years, with the transition expected in the second half of 2026. The company has initiated a search for his successor. During Green’s tenure, sales more than doubled and the company delivered a total shareholder return of approximately 350%.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin